
A tumor that develops in the nasal cavity is called olfactory neuroblastoma, also known as esthesioneuroblastoma. The sensation of smell is produced by neurons and other tissue in the nasal cavity. This kind of tumor begins in the nasal cavity and can grow into the nearby eyes and brain. Olfactory neuroblastoma can potentially extend to other regions of the body, including the neck, lungs, and bones.
Symptoms of olfactory neuroblastoma include:
CausesThe precise cause of olfactory neuroblastoma has not been determined by experts. Generally speaking, DNA alterations in cells cause cancer. The instructions that inform a cell what to do are encoded in its DNA. The modifications instruct the cells to rapidly produce a large number of new cells. When healthy cells would normally die, the alterations allow the cells to survive. Too many cells are produced as a result.
The cells may accumulate into a mass known as a tumor. Healthy body tissue may be invaded and destroyed by the tumor as it grows. Cells may eventually separate and disperse throughout the body.
Risk FactorsIt is thought to be a major risk factor to work in areas where one is exposed to wood dust, metal dusts (nickel, cadmium), wheat, glues, formaldehyde, and other solvents. Olfactory neuroblastoma risk may also be raised by exposure to tobacco smoke.
Complications
The complications of Olfactory Neuroblastoma include:
A new medication called lorlatinib, which was first created to treat adult lung cancers, showed significant promise in early 2023 for treating juvenile cancer neuroblastoma when it is caused by a particular mutation in a protein called ALK.
Certain genetic changes, such as those in the ALK gene, frequently cause neuroblastomas to proliferate. Up to 15% of neuroblastoma patients had the altered ALK gene at diagnosis. High-risk neuroblastoma frequently has these mutations, and children whose malignancies have returned frequently have more of them in their tumors. Physicians can check for these mutations in the clinic and determine which individuals will benefit from particular therapies.
Although the precise origin of olfactory neuroblastoma is unknown, evidence points to a possible connection with chemical exposure. People who are exposed to dangerous chemicals and particles at work or through other activities are more likely to develop malignancies of the nasal cavity, according to research. Wood dust, wheat, glues, nickel and cadmium dust, formaldehyde, and other solvents are a few potential offenders. The development of an olfactory neuroblastoma may potentially be influenced by tobacco smoke. Steer clear of these chemicals as much as you can to protect yourself.
Chemotherapy: Chemotherapy may be used in situations when the tumor has migrated to other body areas. The most often prescribed chemotherapeutic medications for neuroblastoma include vincristine, carboplatin, doxorubicin, cyclophosphamide, and cisplatin.
Cost Start From USD 600 - USD 700Explore Options
Typically, chemotherapy is a systemic treatment. This implies that the medications enter the bloodstream and travel throughout the body to kill cancer cells, including ones that may have separated from the main tumor. The medications can be administered intravenously (IV) or orally. The medications may occasionally be administered safely using a specialized tool known as a central venous catheter. When chemotherapy begins, it is often implanted during surgery and kept there until the end of the course of treatment.
Radiation therapy: Some olfactory neuroblastoma tumors may be treated with radiation therapy. Radiation therapy may be used as the primary treatment or to help lower the likelihood of tumor recurrence following surgery. The success rates for radiation therapy are 90–95% in stage I, 85–90% in stage II, and 75–80% in stage III. The patient is recommended to see the doctor for follow-up every three months following radiation therapy.
Olfactory neuroblastoma is diagnosed by examining the nasal cavity using a number of various scanning techniques. These consist of MRIs, CT scans, and X-rays. A biopsy may be performed by a physician to obtain further information. To ascertain the type of cancer present, a tissue sample is taken and examined under a microscope.
Since neuroblastoma occurs near important structures, patients may require rehab for the following reasons.
Patients may experience changes in their sense of smell due to the tumor's proximity to the olfactory nerves, necessitating olfactory training or adaption techniques. Dryness in the nasal passages is one of the adverse effects of radiation therapy that may necessitate the adoption of extra management techniques. exercises to enhance the function of the muscles of the face, control pain, and encourage the repair of soft tissues. addressing any speech issues that can result from the disruption of surrounding structures after surgery. activities that aid in retraining the sense of smell, if it has been severely compromised. Advice on controlling nutritional requirements in light of possible swallowing issues
The only treatment option is surgery, radiation therapy, and chemotherapy. The most often prescribed chemotherapeutic medications for neuroblastoma include vincristine, carboplatin, doxorubicin, cyclophosphamide, and cisplatin.









Delhi, India

Gurgaon, India

Mumbai, India
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Here are some of the reasons for choosing India:
Due to advancements in medical facilities, such as minimally invasive surgical techniques.
Yes, a group of specialists including radiation oncologists, neurosurgeons, and head and neck surgeons collaborate to create a customized treatment plan for each patient. With treatment, the majority of patients with olfactory neuroblastoma recover.
With skilled neurosurgeons, oncologists and cutting-edge medical technology, India has demonstrated significant success rates in treating olfactory neuroblastoma. The nation's healthcare institutions offer top-notch treatment alternatives, guaranteeing successful outcomes for many patients.
Yes, many Indian hospitals offer the following for olfactory neuroblastoma treatment:
Always consider the following factors when selecting Indian hospitals:
In general, olfactory neuroblastoma treatment has much improved in India. The success rate largely depends on how early diagnosis is made. The 5-year overall survival for olfactory neuroblastoma has been reported to be between 70% to 90%, indicating a positive long-term survival rate. Recurrence is common, though, with a 10-year disease-free survival rate recorded.
You need to keep an eye out for the following signs in them:
Patients with Olfactory Neuroblastoma may experience long-term consequences such as irreversible loss of smell (anosmia), changes in vision, cognitive impairment, and the possibility of spread of tumor to other parts of the body.